"The Directors are not aware of the exact number of securities Mr Khouri holds, as his holdings are part of a larger holding transferred to a separate Share Registry Account controlled by ANZ Nominees Limited apparently on behalf of ANZ Banking Group Limited as result of the Opes Prime position.
However the Directors can state that Mr Khouri’s holdings are definitely significantly less than the holdings declared by the Directors as both direct and indirect holdings in the Annual Report and other relevant ASX documents.
Mr Khouri is not a related party of Solagran nor is he a related party of any of the Directors of Solagran and no ASX announcement has ever been released by Solagran referring to Mr Khouri as a related party."
More importantly:
"The Directors advise the market that Mr Khouri has never attended a Board Meeting of Solagran, has never attended one of the regular management meetings documented by the Company and has had no influence on the strategic policies of the Company.
The Directors were aware of Mr Khouri’s position as a shareholder of BioProspect Limited during their analysis of that company.
Reasons for the Board decision to enter into an agreement with BioProspect were disclosed to the market by way of ASX Announcements and the Board still considers this strategy as necessary for entry by Solagran into the agricultural and animal health markets."